Related Experiment Videos
[Melatonin treatment of a blind child with serious sleep disorders]
Kjersti Ramstad1, Jon Håvard Loge
1Barneavdelingen, seksjon for habilitering Akershus universitetssykehus 1474 Nordbyhagen. kjersti_ramstad@hotmail.com
Insights
Melatonin effectively treated chronic sleep-wake cycle disorders in a blind child with multiple disabilities. This intervention normalized sleep patterns, offering a promising solution for similar pediatric cases.
Area of Science:
- Pediatric Neurology
- Sleep Medicine
- Developmental Disabilities
Background:
- Children with developmental and neurological disabilities frequently experience severe sleep-wake cycle disorders.
- These sleep disturbances can be challenging to manage effectively.
Observation:
- A case study of a 5-year-old blind boy with multiple disabilities presented with a chronic sleep-wake cycle disorder.
- Initial interventions included establishing strict sleep hygiene and reinforcing environmental cues (zeitgebers).
- Melatonin (3 mg nightly) was administered for 4 weeks after an initial 5-month period of behavioral interventions.
Findings:
- Behavioral interventions alone provided only partial improvement in sleep patterns.
- Melatonin administration led to rapid normalization of the boy's sleep pattern within days.
- Sleep problems recurred during periods without melatonin, with no observed side effects.
Implications:
- Melatonin represents a potentially effective treatment for significant sleep problems in blind children with disabilities.
- This finding suggests melatonin could be a valuable therapeutic option for managing pediatric sleep disorders in this population.
- Further research into melatonin's efficacy and safety for similar pediatric cases is warranted.
Background:
Children with developmental and neurological disabilities are prone to develop serious sleep-wake cycle disorders that may be difficult to treat.
Material And Methods:
Case history.
Results:
A 5-year old blind boy with multiple disabilities developed a chronic sleep-wake cycle disorder as his main clinical problem. Treatment included introduction of strict sleep habits and strengthening of environmental "zeitgebers". After five months melatonin 3 mg was administered at night for 4 weeks. The observation period also included 3 weeks without melatonin. Sleep was registered prospectively by a sleep diary. Strict sleep habits combined with strengthening of "zeitgebers" partially improved the sleep problems, but did not establish a normal sleep pattern. When melatonin was added, he normalized his sleep pattern in a few days. His sleep problems returned during the weeks in which he did not receive melatonin. No side effects were observed.
Interpretation:
Melatonin is a promising treatment alternative for serious sleep problems in blind children.